Dynamic behavior analysis of a fractal tumor-immune model with drug resistance

Chemotherapy is a type of treatment that uses drugs to treat cancer and prevent tumor growth. Different chemotherapy protocols and procedures have been developed. Mathematical models have been proposed to analyze the dynamical processes related to cancerous cell proliferation. In this work, we propose a fractal model with healthy, cancerous cells, and chemotherapeutic agents, as well as effector immune cells interacting with cancerous cells. The model incorporates cancer drug resistance as a result of mutation processes triggered by chemotherapy. We demonstrate that the order of our fractal tumor-immune model influences the time evolution of cell population. Considering three different cancer therapy protocols, we observe that the maximum cancerous cells and the time interval for that maximal to be reached depend significantly on the initial conditions of the number of host and cancer cells. Our results show that the protocols play a crucial role in cancer treatment, and the protocol can result in a better result of cancerous cell suppression.

Authors

Institutions

Publication Details

Journal
Physical review. E
Published
2025-07-25
DOI
https://doi.org/10.1103/pmzj-h4bm
Primary Topic
Mathematical Biology Tumor Growth
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dynamic behavior analysis of a fractal tumor-immune model with drug resistance

Enrique C. Gabrick, Ana P. S. Koltun, Kelly C. Iarosz, Antonio Marcos Batista et al.
Physical review. E
Mathematical Biology Tumor Growth
article

Dynamic behavior analysis of a fractal tumor-immune model with drug resistance

Enrique C. Gabrick, Ana P. S. Koltun, Kelly C. Iarosz, Antonio Marcos Batista, José Trobia, Murilo S. Baptista, Diogo L. M. Souza, Moises S. Santos
article en

Abstract

Chemotherapy is a type of treatment that uses drugs to treat cancer and prevent tumor growth. Different chemotherapy protocols and procedures have been developed. Mathematical models have been proposed to analyze the dynamical processes related to cancerous cell proliferation. In this work, we propose a fractal model with healthy, cancerous cells, and chemotherapeutic agents, as well as effector immune cells interacting with cancerous cells. The model incorporates cancer drug resistance as a result of mutation processes triggered by chemotherapy. We demonstrate that the order of our fractal tumor-immune model influences the time evolution of cell population. Considering three different cancer therapy protocols, we observe that the maximum cancerous cells and the time interval for that maximal to be reached depend significantly on the initial conditions of the number of host and cancer cells. Our results show that the protocols play a crucial role in cancer treatment, and the protocol can result in a better result of cancerous cell suppression.

Physical review. EVol. 112(2)
University of Aberdeen (GB), Universitario Francisco de Asís (UY), Universidade Estadual de Ponta Grossa (BR)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Araucária
Openalex Percentile: Top 76%
Mathematical Biology Tumor Growth
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Dynamic behavior analysis of a fractal tumor-immune model with drug resistance — Enrique C. Gabrick, Ana P. S. Koltun, et al. · Physical review. E (2025) | TGRS Research Map | TGRS